[Mutations of the phenylalanine hydroxylase gene in phenylketonuria patients from Shaanxi]. 2014

Rong Qiang, and Wuzhong Yu, and Na Cai, and Xiaobin Wang, and Cuiyun Qin, and Liping Zhang, and Xiaoping Ma, and Lin Wang, and Xuanxing Shi, and Hui Liu, and Xu Li, and Xiang Wang, and Jiang He
Prenatal Diagnosis Center, Shaanxi Maternal and Child Health, Xi'an, Shaanxi 710003, P.R.China. qiangrongshx@126.com.

OBJECTIVE To investigate the feature of phenylalanine hydroxylase (PAH) gene mutations and provide guidance for genetic and prenatal diagnosis of patients with phenylketonuria from Shaanxi. METHODS For 55 patients whose blood Phe concentration was over 2.0 mg/dL, potential mutations in 13 exons and flanking sequences of the PAH gene were detected by PCR and DNA sequencing. RESULTS A total of 98 mutations were detected in 110 PAH alleles, with the detection rate being 89.10%. Nine mutations have been identified in exon 7, which accounted for 33.67% of all. Exon 12 (14.29%) and exon 3 (12.24%) have followed. Thirty eight mutations, locating in exon2-exon12 and the flanking sequence, were detected in the 55 PKU patients. p.R243Q (24.49%) was the commonest mutation, whilstp.A47E, p.I65S and p.A259T were first discovered in China. After querying international databases including PAHdb and HGMD, the p.C334X was verified as the novel PAH gene mutation. CONCLUSIONS The mutation spectrum of the PAH gene in Shaanxi has been identified. And a novel mutation has been identified. This may facilitate the diagnosis of PKU in the future.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010651 Phenylalanine Hydroxylase An enzyme of the oxidoreductase class that catalyzes the formation of L-TYROSINE, dihydrobiopterin, and water from L-PHENYLALANINE, tetrahydrobiopterin, and oxygen. Deficiency of this enzyme may cause PHENYLKETONURIAS and PHENYLKETONURIA, MATERNAL. EC 1.14.16.1. Phenylalanine 4-Hydroxylase,Phenylalanine 4-Monooxygenase,4-Hydroxylase, Phenylalanine,4-Monooxygenase, Phenylalanine,Hydroxylase, Phenylalanine,Phenylalanine 4 Hydroxylase,Phenylalanine 4 Monooxygenase
D010661 Phenylketonurias A group of autosomal recessive disorders marked by a deficiency of the hepatic enzyme PHENYLALANINE HYDROXYLASE or less frequently by reduced activity of DIHYDROPTERIDINE REDUCTASE (i.e., atypical phenylketonuria). Classical phenylketonuria is caused by a severe deficiency of phenylalanine hydroxylase and presents in infancy with developmental delay; SEIZURES; skin HYPOPIGMENTATION; ECZEMA; and demyelination in the central nervous system. (From Adams et al., Principles of Neurology, 6th ed, p952). Biopterin Deficiency,Dihydropteridine Reductase Deficiency Disease,Hyperphenylalaninemia, Non-Phenylketonuric,Phenylalanine Hydroxylase Deficiency Disease,BH4 Deficiency,DHPR Deficiency,Deficiency Disease, Dihydropteridine Reductase,Deficiency Disease, Phenylalanine Hydroxylase,Deficiency Disease, Phenylalanine Hydroxylase, Severe,Dihydropteridine Reductase Deficiency,Folling Disease,Folling's Disease,HPABH4C,Hyperphenylalaninaemia,Hyperphenylalaninemia Caused by a Defect in Biopterin Metabolism,Hyperphenylalaninemia, BH4-Deficient, C,Hyperphenylalaninemia, Tetrahydrobiopterin-Deficient, Due To DHPR Deficiency,Non-Phenylketonuric Hyperphenylalaninemia,Oligophrenia Phenylpyruvica,PAH Deficiency,PKU, Atypical,Phenylalanine Hydroxylase Deficiency,Phenylalanine Hydroxylase Deficiency Disease, Severe,Phenylketonuria,Phenylketonuria I,Phenylketonuria II,Phenylketonuria Type 2,Phenylketonuria, Atypical,Phenylketonuria, Classical,QDPR Deficiency,Quinoid Dihydropteridine Reductase Deficiency,Tetrahydrobiopterin Deficiency,Atypical PKU,Atypical Phenylketonuria,Biopterin Deficiencies,Classical Phenylketonuria,Deficiency, BH4,Deficiency, Biopterin,Deficiency, DHPR,Deficiency, Dihydropteridine Reductase,Deficiency, PAH,Deficiency, Phenylalanine Hydroxylase,Deficiency, QDPR,Deficiency, Tetrahydrobiopterin,Disease, Folling,Disease, Folling's,Hyperphenylalaninemia, Non Phenylketonuric,Non Phenylketonuric Hyperphenylalaninemia,Non-Phenylketonuric Hyperphenylalaninemias
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002681 China A country spanning from central Asia to the Pacific Ocean. Inner Mongolia,Manchuria,People's Republic of China,Sinkiang,Mainland China
D005260 Female Females

Related Publications

Rong Qiang, and Wuzhong Yu, and Na Cai, and Xiaobin Wang, and Cuiyun Qin, and Liping Zhang, and Xiaoping Ma, and Lin Wang, and Xuanxing Shi, and Hui Liu, and Xu Li, and Xiang Wang, and Jiang He
January 2015, SpringerPlus,
Rong Qiang, and Wuzhong Yu, and Na Cai, and Xiaobin Wang, and Cuiyun Qin, and Liping Zhang, and Xiaoping Ma, and Lin Wang, and Xuanxing Shi, and Hui Liu, and Xu Li, and Xiang Wang, and Jiang He
February 2001, Human mutation,
Rong Qiang, and Wuzhong Yu, and Na Cai, and Xiaobin Wang, and Cuiyun Qin, and Liping Zhang, and Xiaoping Ma, and Lin Wang, and Xuanxing Shi, and Hui Liu, and Xu Li, and Xiang Wang, and Jiang He
April 2015, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics,
Rong Qiang, and Wuzhong Yu, and Na Cai, and Xiaobin Wang, and Cuiyun Qin, and Liping Zhang, and Xiaoping Ma, and Lin Wang, and Xuanxing Shi, and Hui Liu, and Xu Li, and Xiang Wang, and Jiang He
December 2012, Genetics and molecular biology,
Rong Qiang, and Wuzhong Yu, and Na Cai, and Xiaobin Wang, and Cuiyun Qin, and Liping Zhang, and Xiaoping Ma, and Lin Wang, and Xuanxing Shi, and Hui Liu, and Xu Li, and Xiang Wang, and Jiang He
September 2019, European journal of medical genetics,
Rong Qiang, and Wuzhong Yu, and Na Cai, and Xiaobin Wang, and Cuiyun Qin, and Liping Zhang, and Xiaoping Ma, and Lin Wang, and Xuanxing Shi, and Hui Liu, and Xu Li, and Xiang Wang, and Jiang He
April 2010, Genetic testing and molecular biomarkers,
Rong Qiang, and Wuzhong Yu, and Na Cai, and Xiaobin Wang, and Cuiyun Qin, and Liping Zhang, and Xiaoping Ma, and Lin Wang, and Xuanxing Shi, and Hui Liu, and Xu Li, and Xiang Wang, and Jiang He
January 1994, Human mutation,
Rong Qiang, and Wuzhong Yu, and Na Cai, and Xiaobin Wang, and Cuiyun Qin, and Liping Zhang, and Xiaoping Ma, and Lin Wang, and Xuanxing Shi, and Hui Liu, and Xu Li, and Xiang Wang, and Jiang He
May 2010, Molecular genetics and metabolism,
Rong Qiang, and Wuzhong Yu, and Na Cai, and Xiaobin Wang, and Cuiyun Qin, and Liping Zhang, and Xiaoping Ma, and Lin Wang, and Xuanxing Shi, and Hui Liu, and Xu Li, and Xiang Wang, and Jiang He
January 1993, Human heredity,
Rong Qiang, and Wuzhong Yu, and Na Cai, and Xiaobin Wang, and Cuiyun Qin, and Liping Zhang, and Xiaoping Ma, and Lin Wang, and Xuanxing Shi, and Hui Liu, and Xu Li, and Xiang Wang, and Jiang He
April 2003, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
Copied contents to your clipboard!